XKL-16686-75757
4 vaccinations
2 coded responses
30 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 641 / MO
- Registered
- 2021-12-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Dose 1 — Pfizer-BioNTech
-
2021-04-15
Dose 2 — Pfizer-BioNTech
-
2021-12-10
Registered in v-safe
-
2021-12-10
Dose 3 — Pfizer-BioNTech
- 2021-12-10
-
2021-12-11
Survey response — days 1–6 daily, dose 3MedDRA: Heart rate increased — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Increased resting heart rateMedDRA releases: 2024-11 · check-in free text available
-
2021-12-12
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-12-13
- 2021-12-14
- 2021-12-15
- 2021-12-16
- 2021-12-17
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-01-14
- 2022-01-21
- 2022-03-11
- 2022-06-10
-
2022-09-18
Dose 4 — Pfizer-BioNTech
- 2022-09-18
-
2022-09-19
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-09-20
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-24
- 2022-09-27
- 2022-10-02
- 2022-10-09
- 2022-10-16
- 2022-10-23
- 2022-10-30
-
2022-12-20
Survey response — 3 months, dose 4MedDRA: Breast feeding, Caesarean section, Office visit — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Issues related to breastfeeding and c section recovery. · Healthcare visit (other): None, just through appts for infant and schedule follow upMedDRA releases: 2024-11 · check-in free text available
-
2022-12-20
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-12-21
- 2023-03-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Pfizer-BioNTech | No |
| 2 | 2021-04-15 | Pfizer-BioNTech | No |
| 3 | 2021-12-10 | Pfizer-BioNTech | No |
| 4 | 2022-09-18 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-20 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Increased resting heart rate
Release 12 — 3 months, dose 4
Symptoms: Issues related to breastfeeding and c section recovery.
Healthcare visit (other): None, just through appts for infant and schedule follow up
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Breast feeding | · | · | ✓ |
| SD | Caesarean section | · | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release